Search details
1.
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Prostate
; 84(3): 292-302, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37964482
2.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36382533
3.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34516663
4.
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Prostate
; 81(7): 433-439, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33792945
5.
Gender Differences in Faculty Rank and Subspecialty Choice among Academic Medical Oncologists.
Cancer Invest
; 39(1): 21-24, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33131319
6.
Germline Testing in Prostate Cancer: When and Who to Test.
Oncology (Williston Park)
; 35(10): 645-653, 2021 10 20.
Article
in English
| MEDLINE | ID: mdl-34669358
7.
Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies.
J Natl Compr Canc Netw
; 18(9): 1150-1155, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32886903
8.
Genetic Testing in Prostate Cancer.
Curr Oncol Rep
; 22(1): 5, 2020 01 23.
Article
in English
| MEDLINE | ID: mdl-31974718
9.
Germline and Somatic Mutations in Prostate Cancer for the Clinician.
J Natl Compr Canc Netw
; 17(5): 515-521, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085765
10.
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL.
Am J Hematol
; 94(4): E117-E116, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30663774
11.
Germline and somatic mutations in prostate cancer: Implications for treatment.
Curr Probl Cancer
; 50: 101101, 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38718711
12.
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
JCO Precis Oncol
; 8: e2300567, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38579192
13.
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
JCO Precis Oncol
; 7: e2200104, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36623239
14.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Article
in English
| MEDLINE | ID: mdl-38072760
15.
Genetic Contribution to Metastatic Prostate Cancer.
Urol Clin North Am
; 48(3): 349-363, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34210490
16.
URINARY EXCRETION OF PLUTONIUM IN MAYAK WORKERS DURING AND AFTER CA-DTPA ADMINISTRATION.
Radiat Prot Dosimetry
; 197(3-4): 154-162, 2021 Dec 30.
Article
in English
| MEDLINE | ID: mdl-34953463
17.
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference.
JAMA Oncol
; 7(1): 107-110, 2021 Jan 01.
Article
in English
| MEDLINE | ID: mdl-33151258
18.
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34778690
19.
Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene Granularity.
Clin Cancer Res
; 26(11): 2439-2440, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32234758
20.
The effects of chronic diseases on plutonium urinary excretion in former workers of the Mayak Production Association.
PLoS One
; 15(11): e0242151, 2020.
Article
in English
| MEDLINE | ID: mdl-33186401